Direct thrombin and factor Xa inhibitors in children: A quest for new anticoagulants for children

Wiener Medizinische Wochenschrift

Volumn 161, Issue 3-4, 2011, Pages 73-79

  Streif, Werner ^a   Ageno, Walter ^b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Anticoagulants; Child; Infant; Review

Indexed keywords

ACENOCOUMAROL; ANTIVITAMIN K; ARGATROBAN; BLOOD CLOTTING FACTOR 10A INHIBITOR; DABIGATRAN ETEXILATE; FONDAPARINUX; HEPARIN; HIRULOG; LOW MOLECULAR WEIGHT HEPARIN; PHENPROCOUMON; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RIVAROXABAN; WARFARIN;

AGE DISTRIBUTION; ANTICOAGULANT THERAPY; ARTICLE; CHILD CARE; DRUG EFFICACY; DRUG METABOLISM; DRUG WITHDRAWAL; FOOD DRUG INTERACTION; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INCIDENCE; POSTTHROMBOSIS SYNDROME; PRACTICE GUIDELINE; STROKE; TREATMENT INDICATION; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ANTICOAGULANTS; BENZIMIDAZOLES; BETA-ALANINE; CHILD; CHILD, PRESCHOOL; DRUG APPROVAL; FACTOR XA; HIRUDINS; HUMANS; INFANT; INFANT, NEWBORN; MORPHOLINES; PEPTIDE FRAGMENTS; PIPECOLIC ACIDS; POLYSACCHARIDES; RECOMBINANT PROTEINS; RISK FACTORS; THIOPHENES; THROMBIN; VENOUS THROMBOEMBOLISM;

EID: 79953331810     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-011-0879-5     Document Type: Article

References (37)

1. AK Chan G de Veber P Monagle LA Brooker PM Massicotte 2003 Venous thrombosis in children J Thromb Haemost 1 7 1443 1455 12871279 10.1046/j.1538-7836.2003.00308.x 1:STN:280:DC%2BD3szjvFOguw%3D%3D
2. S Parasuraman SZ Goldhaber 2006 Venous thromboembolism in children Circulation 113 2 e12 e16 16418440 10.1161/CIRCULATIONAHA.105.583773
3. FR Rosendaal 1997 Thrombosis in the young: epidemiology and risk factors. A focus on venous thrombosis Thromb Haemost 78 1 1 6 9198119 1:CAS:528:DyaK2sXktFemur4%3D (Pubitemid 27289208)
4. L Raffini YS Huang C Witmer C Feudtner 2009 Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007 Pediatrics 124 4 1001 1008 19736261 10.1542/peds.2009-0768
5. NA Goldenberg MP Donadini SR Kahn M Crowther G Kenet U Nowak-Gottl, et al. 2010 Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors Haematologica 95 11 1952 1959 20595095 10.3324/haematol.2010.026989
6. S Kuhle P Massicotte A Chan M Adams M Abdolell G de Veber, et al. 2004 Systemic thromboembolism in children. Data from the 1-800-NO-CLOTS Consultation Service Thromb Haemost 92 4 722 728 15467901 1:CAS:528:DC%2BD2cXovVOlsLg%3D
7. P Monagle E Chalmers A Chan G deVeber F Kirkham P Massicotte, et al. 2008 Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 6 Suppl. 887S 968S 18574281 10.1378/chest.08-0762 1:CAS:528:DC%2BD1cXptVKhsLs%3D (Pubitemid 351892979)
8. A Encke S Haas S Sauerland HH Abholz MW Beckmann C Bode, et al. 2009 S3-Leitlinie: Prophylaxe der venösen Thromboembolie (VTE) Vasa 38 S76 1 131 10.1024/0301-1526.38.S76.1
9. CH van Ommen H Heijboer HR Buller RA Hirasing HS Heijmans M Peters 2001 Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands J Pediatr 139 5 676 681 11713446 10.1067/mpd.2001.118192 1:STN:280:DC%2BD3MnmslOiuw%3D%3D (Pubitemid 33097433)
10. P Monagle M Adams M Mahoney K Ali D Barnard M Bernstein, et al. 2000 Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry Pediatr Res 47 6 763 766 10832734 10.1203/00006450-200006000-00013 1:STN:280:DC%2BD3cvit1ejtA%3D%3D (Pubitemid 30365435)
11. M Andrew M David M Adams K Ali R Anderson D Barnard, et al. 1994 Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE Blood 83 5 1251 1257 8118029 1:STN:280:DyaK2c7mt1KhsQ%3D%3D (Pubitemid 24062848)
12. K Kurnik C Duering C Bidlingmaier U Nowak-Gottl 2005 Thromboembolism in neonates and infants: impact of underlying diseases, prothrombotic risk factors and treatment modalities Thromb Res 115 Suppl. 1 71 77 15790161
13. TT Biss LR Brandao WH Kahr AK Chan S Williams 2008 Clinical features and outcome of pulmonary embolism in children Br J Haematol 142 5 808 818 18564359 10.1111/j.1365-2141.2008.07243.x
14. C Barnes F Newall P Monagle 2002 Post-thrombotic syndrome Arch Dis Child 86 3 212 214 11861250 10.1136/adc.86.3.212 1:STN:280:DC%2BD387isFyqtw%3D%3D (Pubitemid 34250873)
15. CH van Ommen H Heijboer EJ van den Dool BA Hutten M Peters 2003 Pediatric venous thromboembolic disease in one single center: congenital prothrombotic disorders and the clinical outcome J Thromb Haemost 1 12 2516 2522 14675086 10.1046/j.1538-7836.2003.00465.x 1:CAS:528:DC%2BD2cXktFOlsLY%3D
16. C Green MD Yohannan 1998 Umbilical arterial and venous catheters: placement, use, and complications Neonatal Netw 17 6 23 28 9832755 1:STN:280:DyaK1M%2FkvF2nuw%3D%3D
17. W Streif M Andrew V Marzinotto P Massicotte AK Chan JA Julian, et al. 1999 Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients Blood 94 9 3007 3014 10556183 1:CAS:528:DyaK1MXntVSrsbg%3D (Pubitemid 29512704)
18. M Andrew V Marzinotto P Massicotte V Blanchette J Ginsberg P Brill-Edwards, et al. 1994 Heparin therapy in pediatric patients: a prospective cohort study Pediatr Res 35 1 78 83 8134203 10.1203/00006450-199401000-00016 1:STN:280:DyaK2c7otFelsQ%3D%3D (Pubitemid 24004639)
19. S Kuhle P Eulmesekian B Kavanagh P Massicotte P Vegh LG Mitchell 2007 A clinically significant incidence of bleeding in critically ill children receiving therapeutic doses of unfractionated heparin: a prospective cohort study Haematologica 92 2 244 247 17296576 10.3324/haematol.10616 1:CAS:528:DC%2BD2sXhtFGqurfI
20. P Massicotte JA Julian M Gent K Shields V Marzinotto B Szechtman, et al. 2003 An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial Thromb Res 109 2-3 85 92 12706636 10.1016/S0049-3848(03)00059-8 1:CAS:528:DC%2BD3sXjtFWgtrg%3D (Pubitemid 36428758)
21. W Streif G Goebel AK Chan MP Massicotte 2003 Use of low molecular mass heparin (enoxaparin) in newborn infants: a prospective cohort study of 62 patients Arch Dis Child Fetal Neonatal Ed 88 5 F365 F370 12937038 10.1136/fn.88.5.F365 1:STN:280:DC%2BD3szpslKqug%3D%3D
22. W Streif 2009 Prevention of perioperative venous thromboembolism in children Wien Med Wochenschr 159 19-20 481 486 19898787 10.1007/s10354-009-0712- 6
23. M Schmugge L Risch AR Huber A Benn JE Fischer 2002 Heparin-induced thrombocytopenia-associated thrombosis in pediatric intensive care patients Pediatrics 109 1 E10 11773578 10.1542/peds.109.1.e10
24. GK Lo D Juhl TE Warkentin CS Sigouin P Eichler A Greinacher 2006 Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings J Thromb Haemost 4 4 759 765 16634744 10.1111/j.1538-7836.2006.01787.x 1:STN:280: DC%2BD283ivVyjtQ%3D%3D
25. MJ Hursting J Dubb CN Verme-Gibboney 2006 Argatroban anticoagulation in pediatric patients: a literature analysis J Pediatr Hematol Oncol 28 1 4 10 16394885 10.1097/01.mph.0000195296.48319.38 1:CAS:528:DC%2BD28XhsFaqtrY%3D (Pubitemid 43361611)
26. Young G. New anticoagulants in children. Hematology Am Soc Hematol Educ Program, 245-250, 2008
27. S Rayapudi A Torres Jr GG Deshpande MP Ross JD Wohrley G Young, et al. 2008 Bivalirudin for anticoagulation in children Pediatr Blood Cancer 51 6 798 801 18819124 10.1002/pbc.21731
28. G Young MD Tarantino J Wohrley LC Weber M Belvedere DJ Nugent 2007 Pilot dose-finding and safety study of bivalirudin in infants < 6 months of age with thrombosis J Thromb Haemost 5 8 1654 1659 17663736 10.1111/j.1538-7836. 2007.02623.x 1:CAS:528:DC%2BD2sXhtVent7zF (Pubitemid 47091407)
29. S Kuhle P Eulmesekian B Kavanagh P Massicotte P Vegh A Lau, et al. 2007 Lack of correlation between heparin dose and standard clinical monitoring tests in treatment with unfractionated heparin in critically ill children Haematologica 92 4 554 557 17488668 10.3324/haematol.10696 1:CAS:528: DC%2BD2sXhtFKrsrjK (Pubitemid 350144302)
30. EF Grabowski JB Bussel 2006 Pediatric experience with fondaparinux in deep venous thrombosis ASH Annual Meeting Abstracts 108 11 916
31. G Young DL Yee R Khanna SO MD DJ Nugent 2009 Fondaparinux for the treatment of thrombosis in children: a prospective, dose-finding, pharmacodynamic and safety study ASH Annual Meeting Abstracts 114 22 3130
32. V Ignjatovic R Summerhayes YY Yip P Monagle 2008 The in vitro anticoagulant effects of danaparoid, fondaparinux, and lepirudin in children compared to adults Thromb Res 122 5 709 714 18384841 10.1016/j.thromres.2008.02. 001 1:CAS:528:DC%2BD1cXhtVals77P
33. M Andrew B Paes R Milner M Johnston L Mitchell DM Tollefsen, et al. 1987 Development of the human coagulation system in the full-term infant Blood 70 1 165 172 3593964 1:CAS:528:DyaL2sXlsleiu7k%3D (Pubitemid 17111257)
34. M Andrew P Vegh M Johnston J Bowker F Ofosu L Mitchell 1992 Maturation of the hemostatic system during childhood Blood 80 8 1998 2005 1391957 1:STN:280:DyaK3s%2FgsVOlsA%3D%3D
35. Young G, Boshkov LK, Sullivan JE, Raffini LJ, Cox DS, Boyle DA, et al. Argatroban therapy in pediatric patients requiring nonheparin anticoagulation: an open-label, safety, efficacy, and pharmacokinetic study. Pediatr Blood Cancer, e-publication Nov 5, 2010
36. JM Walenga C Adiguzel 2010 Drug and dietary interactions of the new and emerging oral anticoagulants Int J Clin Pract 64 7 956 967 20584229 10.1111/j.1742-1241.2009.02286.x 1:CAS:528:DC%2BC3cXnsFOmtLk%3D
37. MM Samama J Amiral C Guinet E Perzborn F Depasse 2010 An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasma Thromb Haemost 104 5 1078 1079 20806114 1:CAS:528:DC%2BC3cXhsFaht7rM